 |
 |
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
 |
|
Top from left: Dr. John Dick, Dr. David Jaffray, Dr. Mary Gospodarowicz, Dr. Tak Mak, Dr. James Till, Dr. Ernest McCulloch, Dr. Donna Reece.
Bottom from left: Krystyna Moore, RN, Dr. Malcolm Moore, Dr. Frances Shepherd. |
Here are some of the many honours awarded to members of the Princess Margaret Hospital community during the year.
Dr. John (Jack) Cunningham, Senior Scientist, 1958-1989, and medical physicist, was named Officer of the Order of Canada, recognizing a lifetime of achievement. Dr. Cunningham developed innovative concepts and methods for radiation dose calculations used to treat cancer patients around the world.
Dr. John Dick, Senior Scientist, Division of Cellular and Molecular Biology and current Canada Research Chair in Stem Cell Biology, University Health Network, was awarded the William Dameshek Prize from the American Society of Hematology. This honour is given to individuals who have made an outstanding contribution in hematology.
Dr. David Jaffray, Head, Radiation Physics, was voted by readers of the journal Medical Imaging as one of the top 10 radiation oncology/cancer researchers in the field. He is the only non-MD on the list.
Dr. Tak Mak, Director, The Campbell Family Institute of Breast Cancer Research and Director, the Advanced Medical Discovery Institute, has been elected as a full honorary member of the American Academy of Arts & Sciences.
Drs. Ernest McCulloch, James Till and Tak Mak were honoured by the Canadian Institutes of Health Research and the Ontario Cancer Research Network as three of the four top Canadian scientists for their contributions to cancer research.
Krystyna Moore, RN case manager and Dr. Donna Reece, medical oncologist, received the Gerald Kirsh Humanitarian Awards. Patients and their families nominate caregivers who demonstrate compassionate care and two winners are peer-selected from among them.
Dr. Mary Gospodarowicz was named Medical Director, Oncology Blood Disorders Program. She continues as Chief, Radiation Medicine Program.
Drs. Amit Oza, Malcolm Moore and Lillian Siu were successful in renewing the Phase II Drug Development program. This program was one of nine successful applications across North America - and the only Canadian network – chosen by the U.S. National Cancer Institute to develop new anti-cancer agents.
Dr. Frances Shepherd, Leader, Lung Cancer Site Group at PMH, received the 2006 O. Harold Warwick Prize for Cancer Research from the National Cancer Institute of Canada. In November 2005, the Foundation saluted Dr. Shepherd as “a visionary leader for her heroic work, compassion and commitment to lung cancer patients and their families” at a special tribute evening.
Dr. David Wiljer, PMH Research Information Manager, and colleagues Dr. Mark Minden, Sima Bogomilsky, Janice Stewart, Cindy Murray, Lydia Lee and Dr. Pamela Catton received the Innovation Award in the category “Improving Efficiency Through Process Redesign” at Celebrating Innovations in Health Care Expo, designed to profile the diversity of innovation that is improving Ontario's health care system, organized by the Ministry of Health and Long Term Care. |